Hunter RL - Search Results

1

Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.

Wang R, Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G, Alving CR, Church P, Hoffman SL. Wang R, et al. Among authors: hunter rl. J Immunol. 1995 Mar 15;154(6):2784-93. J Immunol. 1995. PMID: 7876549

2

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.

Le TP, Church LW, Corradin G, Hunter RL, Charoenvit Y, Wang R, de la Vega P, Sacci J, Ballou WR, Kolodny N, Kitov S, Glenn GM, Richards RL, Alving CR, Hoffman SL. Le TP, et al. Among authors: hunter rl. Vaccine. 1998 Jan-Feb;16(2-3):305-12. doi: 10.1016/s0264-410x(97)00165-5. Vaccine. 1998. PMID: 9607047

3

Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.

Wang R, Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G, Alving CR, Church P, Hoffman SL. Wang R, et al. Among authors: hunter rl. J Immunol. 1995 Aug 1;155(3):1637. J Immunol. 1995. PMID: 7636221 No abstract available.

4

Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.

Hunter RL, Kidd MR, Olsen MR, Patterson PS, Lal AA. Hunter RL, et al. J Immunol. 1995 Feb 15;154(4):1762-9. J Immunol. 1995. PMID: 7836760

5

Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.

ten Hagen TL, Sulzer AJ, Kidd MR, Lal AA, Hunter RL. ten Hagen TL, et al. Among authors: hunter rl. J Immunol. 1993 Dec 15;151(12):7077-85. J Immunol. 1993. PMID: 8258712

6

Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection.

Kalish ML, Check IJ, Hunter RL. Kalish ML, et al. Among authors: hunter rl. J Immunol. 1991 May 15;146(10):3583-90. J Immunol. 1991. PMID: 2026882

7

Use of the rhesus monkey as an experimental model to test the degree of efficacy of an anti-sporozoite peptide malaria vaccine candidate combined with copolymer-based adjuvants.

Millet P, Grady KK, Olsen M, Galland GG, Sullivan JS, Morris CL, Richardson BB, Collins WE, Hunter RL. Millet P, et al. Among authors: hunter rl. Am J Trop Med Hyg. 1995 Apr;52(4):328-35. doi: 10.4269/ajtmh.1995.52.328. Am J Trop Med Hyg. 1995. PMID: 7741171

8

Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine.

Millet P, Kalish ML, Collins WE, Hunter RL. Millet P, et al. Among authors: hunter rl. Vaccine. 1992;10(8):547-50. doi: 10.1016/0264-410x(92)90355-n. Vaccine. 1992. PMID: 1377851

9

Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.

Reed RC, Louis-Wileman V, Wells RL, Verheul AF, Hunter RL, Lal AA. Reed RC, et al. Among authors: hunter rl. Vaccine. 1996 Jun;14(8):828-36. doi: 10.1016/0264-410x(95)00175-z. Vaccine. 1996. PMID: 8817831

10

Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.

Yang C, Collins WE, Xiao L, Saekhou AM, Reed RC, Nelson CO, Hunter RL, Jue DL, Fang S, Wohlhueter RM, Udhayakumar V, Lal AA. Yang C, et al. Among authors: hunter rl. Vaccine. 1997 Mar;15(4):377-86. doi: 10.1016/s0264-410x(97)00200-4. Vaccine. 1997. PMID: 9141208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters